Nutrients and ageing: What can we learn about ageing interactions from animal biology?

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 19, Issue 1, 2016, Pages 19-25

  Stenvinkel, Peter ^a   Kooman, Jeroen P ^b   Shiels, Paul G ^c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

biomimicry; caloric restriction; naked mole rat; oxidative stress; premature ageing; resveretarol

Indexed keywords

GLUCOSE; INSULIN; MAMMALIAN TARGET OF RAPAMYCIN; RESVERATROL; SOMATOMEDIN C; TRANSCRIPTION FACTOR FOXO; ANTIOXIDANT; STILBENE DERIVATIVE;

AGING; ANIMAL BIOLOGY; BIOLOGY; BODY COMPOSITION; BONE DENSITY; CALORIC RESTRICTION; CELL COMMUNICATION; DIPTERA; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA METHYLATION; EPIGENETICS; GASTROINTESTINAL TRACT FUNCTION; GENOMIC INSTABILITY; GLUCOSE BLOOD LEVEL; HEART PROTECTION; HETEROCEPHALUS; HUMAN; INSULIN SENSITIVITY; LIBIDO DISORDER; LIFE EXTENSION; LONGEVITY; METABOLISM; MINERAL INTAKE; MOLECULAR GENETICS; MORBIDITY; MORTALITY; NONHUMAN; NUTRITION; NUTRITIONAL HEALTH; NUTRITIONAL STATUS; OXIDATIVE STRESS; PRIMATE; PROGERIA; PROTEIN EXPRESSION; PROTEIN HOMEOSTASIS; PROTEIN RESTRICTION; QUALITY OF LIFE; REPRODUCTIVE HEALTH; REVIEW; RISK FACTOR; SENESCENCE; SIGNAL TRANSDUCTION; SURVIVAL; TELOMERE; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION; WORM; ANIMAL; DIET; DRUG EFFECTS; MOLE RAT; PHYSIOLOGY;

AGING; ANIMALS; ANTIOXIDANTS; CALORIC RESTRICTION; DIET; HUMANS; LONGEVITY; MOLE RATS; OXIDATIVE STRESS; STILBENES;

EID: 84951907576     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0000000000000234     Document Type: Review

References (76)

1. Gonzalo S, Kreienkamp R. DNA repair defects and genome instability in Hutchinson-Gilford Progeria Syndrome. Curr Opin Cell Biol 2015; 34:75-83.
2. Lessel D, Hisama FM, Szakszon K, et al. POLD1 germline mutations in patients initially diagnosed with Werner syndrome. Hum Muta 2015. (In press).
3. Stenvinkel P, Larsson TE. Chronic kidney disease: a clinical model of premature aging. Am J Kidney Dis 2013; 62:339-351.
4. Kooman JP, Kotanko P, Schols AM, et al. Chronic kidney disease and premature ageing. Nat Rev Nephrol 2014; 10:732-742.
5. Kooman JP, Shiels PG, Stenvinkel P. Premature aging in chronic kidney disease and chronic obstructive pulmonary disease: similarities and differences. Curr Opin Clin Nutr Metab Care 2015. (In press).
6. Pathai S, Lawn SD, Gilbert CE, et al. Accelerated biological ageing in HIVinfected individuals in South Africa: a case-control study. AIDS 2013; 27:2375-2384.
7. Blagosklonny MV. Prospective treatment of age-related diseases by slowing down aging. Am J Pathol 2012; 181:1142-1146.
8. Christensen K, Thinggaard M, McGue M, et al. Perceived age as clinically useful biomarker of ageing: cohort study. BMJ 2009; 339:b5262.
9. Horwarth S. DNA methylation age of human tissues and cell types. Genome Biol 2013; 14:R115.
10. Weidner CI, Wagner W. The epigenetic tracks of aging. Biol Chem 2014; 395:1307-1314.
11. Marioni RE, Shah S, McRae AF, et al. DNA methylation age of blood predicts all-cause mortality in later life. Genome Biol 2015; 16:25.
12. Jones MJ, Goodman SJ, Kobor MS. DNA methylation and healthy human aging. Aging Cell 2015. (In press).
13. López-Otín C, Blasco MA, Partridge L, et al. The hallmarks of aging. Cell 2013; 153:1194-1217.
14. Longo VD, Antebi A, Bartke A, et al. Interventions to slow aging in humans: are we ready? Aging Cell 2015; 14:497-510.
15. Newgard CB, Sharpless NE. Coming of age: molecular drivers of aging and therapeutic opportunities. J Clin Invest 2013; 123:946-950.
16. Mannick JB, Del Giudice G, Lattanzi M, et al. mTOR inhibition improves immune function in the elderly. Sci Transl Med 2014; 6:268ra179.
17. Miles JM, Rule AD, Borlaug BA. Use of metformin in diseases of aging. Curr Diab Rep 2014; 14:490.
18. Na HJ, Park JS, Pyo JH, et al. Metformin inhibits age-related centrosome amplification in Drosophila midgut stem cells through AKT/TOR pathway. Mech Ageing Dev 2015; 149:8-18.
19. Forouzandeh F, Salazar G, Patrushev N, et al. Metformin beyond diabetes: pleiotropic benefits of metformin in attenuation of atherosclerosis. J Am Heart Assoc 2014; 3:e001202.
20. Vigili de Kreutzenberg S, Ceolotto G, Cattelan A, et al. Metformin improves putative longevity effectors in peripheral mononuclear cells from subjects with prediabetes: a randomized controlled trial. Nutr Metab Cardiovasc Dis 2015; 25:686-693.
21. Cauchy F, Mebarki M, Albuquerque M, et al. Antiangiogenic effect of metformin in human liver carcinogenesis related to metabolic syndrome. Gut 2015; 64:1498-1500.
22. Fontana L, Partridge L, Longo VD. Extending healthy life span: from yeasts to humans. Science 2010; 328:321-326.
23. Colman RJ, Beasley TM, Kemnitz JW, et al. Caloric restriction reduces agerelated and all-cause mortality in rhesus monkeys. Nat Commun 2014; 5:3557.
24. Colman RJ, Anderson RM, Johnson SC, et al. Caloric restriction delays disease onset and mortality in rhesus monkeys. Science 2009; 325:201-204.
25. Ravussin E, Redman LM, Rochon J, et al. A 2-Year randomized controlled trial of human caloric restriction: feasibility and effects on predictors of health span and longevity. J Gerontol A Biol Sci Med Sci 2015; 70:1097-1104.
26. Noordam R, Gunn DA, Tomlin CC, et al. High serum glucose levels are associated with a higher perceived age. Age (Dordr) 2013; 35:189-195.
27. Csiszar A, Gautam T, Sosnowska D, et al. Caloric restriction confers persistent antioxidative, pro-angiogenic, and anti-inflammatory effects and promotes antiaging miRNA expression profile in cerebromicrovascular endothelial cells of aged rats. Am J Physiol Heart Circ Physiol 2014; 307:H292-306.
28. Putti R, Sica R, Migliaccio V, Lionetti L. Diet impact on mitochondrial bioenergetics and dynamic. Front Physiol 2015; 6:109.
29. Long YC, Tan TM, Takao I, Tang BL. The biochemistry and cell biology of aging: metabolic regulation through mitochondrial signaling. Am J Physiol Endocrinol Metab 2014; 306:E581-E591.
30. Blagosklonny MV. Calorie restriction: decelerating mTOR-driven aging from cells to organisms (including humans. Cell Cycle 2010; 9:683-688.
31. Radak Z, Koltai E, Taylor AW, et al. Redox-regulating sirtuins in aging, caloric restriction, and exercise. Free Radic Biol Med 2013; 58:87-97.
32. Gu Y, Honig LS, Schupf N, et al. Mediterranean diet and leukocyte telomere length in a multiethnic elderly population. Age (Dordr) 2015; 37:24.
33. Gu Y, Honig LS, Schupf N, et al. Mediterranean diet and cognitive function: the SUN project. J Nutr Health Aging 2015; 19:305-312.
34. Prinelli F, Yannakoulia M, Anastasiou CA, et al. Mediterranean diet and other lifestyle factors in relation to 20-year all-cause mortality: a cohort study in an Italian population. Br J Nutr 2015; 113:1103-1111.
35. Anisimov VN. Conservative growth hormone/IGF-1 and mTOR signaling pathways as a target for aging and cancer prevention: do we really have an antiaging drug? Interdiscip Top Gerontol 2014; 40:177-188.
36. Riedel CG, Dowen RH, Lourenco GF, et al. DAF-16 employs the chromatin remodeller SWI/SNF to promote stress resistance and longevity. Nat Cell Biol 2013; 15:491-501.
37. Levine ME, Suarez JA, Brandhorst S, et al. Low protein intake is associated with a major reduction in IGF-1, cancer, and overall mortality in the 65 and younger but not older population. Cell Metab 2014; 19:407-417.
38. Ortega-Molina A, Efeyan A, Lopez-Guadamillas E, et al. Pten positively regulates brown adipose function, energy expenditure, and longevity. Cell Metab 2012; 15:382-394.
39. Foukas LC, Bilanges B, Bettedi L, et al. Long-term p110a PI3K inactivation exerts a beneficial effect on metabolism. EMBO Mol Med 2013; 5:563-581.
40. Hill CM, Arum O, Boparai RK, et al. Female PAPP-A knockout mice are resistant to metabolic dysfunction induced by high-fat/high-sucrose feeding at middle age. Age (Dordr) 2015; 37:9765.
41. Sopjani M, Rinnerthaler M, Kruja J, Dermaku-Sopjani M. Intracellular signaling of the aging suppressor protein Klotho. Curr Mol Med 2015; 15:27-37.
42. Garinis GA, van der Horst GT, Vijg J, Hoeijmakers JH. DNA damage and ageing: new-age ideas for an age-old problem. Nat Cell Biol 2008; 10:1241-1247.
43. Dabhade P, Kotwal S. Tackling the aging process with bio-molecules: a possible role for caloric restriction, food-derived nutrients, vitamins, amino acids, peptides, and minerals. J Nutr Gerontol Geriatr 2013; 32:24-40.
44. Hall JA, Dominy JE, Lee Y, Puigserver P. The sirtuin family's role in aging and age-associated pathologies. J Clin Invest 2013; 123:973-979.
45. Ramis MR, Esteban S, Miralles A, et al. Caloric restriction, resveratrol and melatonin: Role of SIRT1 and implications for aging and related diseases. Mech Ageing Dev 2015; 148:28-41.
46. Valenzano DR, Terzibasi E, Genade T, et al. Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate. Curr Biol 2006; 16:296-300.
47. Burnett C, Valentini S, Cabreiro F, et al. Absence of effects of Sir2 overexpression on lifespan in C. elegans and Drosophila. Nature 2011; 477:482-485.
48. Smoliga JM, Baur JA, Hausenblas HA. Resveratrol and health - a comprehensive review of human clinical trials. Mol Nutr Food Res 2013; 55:1129-1141.
49. Zhu Y, Tchkonia T, Pirtskhalava T, et al. The Achilles' heel of senescent cells: from transcriptome to senolytic drugs. Aging cell 2015; 14:644-658.
50. Mattson MP, Cutler RG, Camandola S. Energy intake and amyotrophic lateral sclerosis. Neuromolecular Med 2007; 9:17-20.
51. Stenvinkel P, Johnson RJ. Kidney biomimicry - a rediscovered scientific field that could provide hope to patients with kidney disease. Arch Med Res 2013; 44:584-590.
52. Kenyon CJ. The genetics of aging. Nature 2010; 464:504-512.
53. Finch CE. Update on slow aging and negligible senescence - a mini review. Gerontology 2009; 55:307-311.
54. Buffenstein R. Negligible senescence in the longest living rodent, the naked mole-rat: insights from a successfully aging species. J Comp Physiol B 2008; 4:439-445.
55. Skulachev MV, Severin FF, Skulachev VP. Aging as an evolvability-increasing program which can be switched off by organism to mobilize additional resources for survival. Curr Aging Sci 2015; 8:95-109.
56. Hulbert AJ, Pamplona R, Buffenstein WA, Buttemer WA. Life and death: metabolic rate, membrane composition, and life span of animals. Physiol Rev 2007; 87:1175-1213.
57. Buffenstein R, Pinto M. Endocrine function in naturally long-living small species. Mol Cell Endocrinol 2009; 299:101-111.
58. Finch CE. Update on slow aging and negligible senescence - a mini-review. Gerontology 2009; 55:307-313.
59. Lewis KN, Mele J, Hornsby PJ, Buffenstein R. Stress resistance in the naked mole-rat: the bare essentials - a mini-review. Gerontology 2012; 58:453-462.
60. O'Connor TP, Lee A, Jarvis JU, Buffenstein R. Prolonged longevity in naked mole-rats: age-related changes in metabolism, body composition and gastrointestinal function. Comp Biochem Physiol A Mol Integr Physiol 2002; 133:835-842.
61. Park TJ, Lu Y, Jüttner R, et al. Selective inflammatory pain insensitivity in the African naked mole-rat (Heterocephalusglaber). PLoS Biol 2008; 6:e13.
62. Grimes KM, Lindsey ML, Gelfond JA, Buffenstein R. Getting to the heart of the matter: age-related changes in diastolic heart function in the longest-lived rodent, the naked mole rat. J Gerontol A Biol Sci Med Sci 2012; 67:384-394.
63. Grimes KM, Reddy AK, Lindsey ML, Buffenstein R. And the beat goes on: maintained cardiovascular function during aging in the longest-lived rodent, the naked mole-rat. Am J Physiol Heart Circ Physiol 2014; 307:H284-H291.
64. Dai DF, Wessells RJ, Rabinovitch PS. Cardiac aging. In: Wolf NS, editor. The comparative biology of aging. Seattle: Springer; 2010. pp. 259-286.
65. Tian X, Azpurua J, Hine C, et al. High-molecular-mass hyaluronan mediates the cancer resistance of the naked mole rat. Nature 2013; 499:346-349.
66. Yang Z, Zhang Y, Chen L. Single amino acid changes in naked mole rat may reveal new anticancer mechanisms in mammals. Gene 2015; 572:101-107.
67. Thieme R, Kurz S, Kolb M, et al. Analysis of a2 macroglobulin from the longlived and cancer-resistant naked mole-rat and human plasma. PLoS One 2015; 10:e0130470.
68. Lewis KN, Andziak B, Yang T, Buffenstein R. The naked mole-rat response to oxidative stress: just deal with it. Antioxid Redox Signal 2013; 19:1388-1399.
69. Lewis KN, Wason E, Edrey YH, et al. Regulation of Nrf2 signaling and longevity in naturally long-lived rodents. Proc Natl Acad Sci U S A 2015; 112:3722-3727.
70. Ruiz S, Pergola PE, Zager RA, Vaziri ND. Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease. Kidney Int 2013; 83:1029-1041.
71. Boutten A, Goven D, Artaud-Macari E, et al. NRF2 targeting: a promising therapeutic strategy in chronic obstructive pulmonary disease. Trends Mol Med 2011; 17:363-371.
72. De Waal EM, Liang H, Pierce A, et al. Elevated protein carbonylation and oxidative stress do not affect protein structure and function in the long-living naked-mole rat: a proteomic approach. Biochem Biophys Res Commun 2013; 434:815-819.
73. Triplett JC, Tramutola A, Swomley A, et al. Age-related changes in the proteostasis network in the brain of the naked mole-rat: Implications promoting healthy longevity. Biochim Biophys Acta 2015; 1852 (10 Pt A):2213-2224.
74. Edrey YH, Medina DX, Gaczynska M, et al. Amyloid beta and the longest-lived rodent: the naked mole-rat as a model for natural protection from Alzheimer's disease. Neurobiol Aging 2013; 34:2352-2360.
75. Manson JE, Bassuk SS. Vitamin D research clinical practice. at a crossroads. JAMA 2015; 313:1311-1312.
76. Schöttker B, Brenner H. Vitamin D as a resilience factor, helpful for survival of potentially fatal conditions: a hypothesis emerging from recent findings of the ESTHER Cohort Study and the CHANCES Consortium. Nutrients 2015; 7:3264-3278.